Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3932449 | Fertility and Sterility | 2011 | 4 Pages |
Abstract
In this observational trial, we compared the impact on two different strategies, egg vitrification (n = 152) obtained after triggering final oocyte maturation with GnRH agonists and transferring the embryos at a later stage, with classical coasting (n = 96) to avoid OHSS in patients at risk due to high response to COH. Our results show that oocyte vitrification after GnRH agonists triggering is a highly attractive, safe, and efficient alternative to postpone embryo transfer in patients at high risk of OHSS, resulting in decreased risk for the patient and a better cycle outcome (pregnancy rate 50% vs 29.5%).
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Leyre Herrero, Sandra Pareja, Carolina Losada, Ana Cristina Cobo, Antonio Pellicer, Juan Antonio Garcia-Velasco,